SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-584558
Filing Date
2016-05-10
Accepted
2016-05-10 06:04:37
Documents
5
Period of Report
2016-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d185327d8k.htm 8-K 36071
2 EX-2.1 d185327dex21.htm EX-2.1 634928
3 EX-10.1 d185327dex101.htm EX-10.1 662477
4 EX-99.1 d185327dex991.htm EX-99.1 16231
5 GRAPHIC g185327ex991logo.jpg GRAPHIC 20014
  Complete submission text file 0001193125-16-584558.txt   1378619
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51820 | Film No.: 161633573
SIC: 2834 Pharmaceutical Preparations